A PILOT-STUDY OF A NEW THERAPEUTIC APPROACH IN THE TREATMENT OF LOCALLY ADVANCED STAGES OF RECTAL-CANCER - NEOADJUVANT RADIATION, CHEMOTHERAPY AND REGIONAL HYPERTHERMIA
H. Riess et al., A PILOT-STUDY OF A NEW THERAPEUTIC APPROACH IN THE TREATMENT OF LOCALLY ADVANCED STAGES OF RECTAL-CANCER - NEOADJUVANT RADIATION, CHEMOTHERAPY AND REGIONAL HYPERTHERMIA, European journal of cancer, 31A(7-8), 1995, pp. 1356-1360
The synergistic effects of hyperthermia (temperatures greater than or
equal to 41 degrees C) when combined with radiotherapy or cytotoxic dr
ugs, as well as a modulation of tumour-related immunological phenomena
have been demonstrated preclinically. Local or regional hyperthermia
in combination with radiation or chemotherapy has been studied in pati
ents during recent years, and has convincingly demonstrated that hyper
thermia is feasible and tolerated by patients. Furthermore, there is s
trong evidence that hyperthermia may provide an improvement in local c
ontrol as compared with radiotherapy or chemotherapy alone. Systems ba
sed on radiowave irradiation allow sufficiently tolerable and effectiv
e regional hyperthermic therapy in patients with rectal carcinomas. Us
ed as part of curative pre-operative and postoperative multimodal ther
apeutic strategies in high-risk patients with locally advanced rectal
carcinomas, hyperthermia may result in improved local control and a hi
gher rate of sphincter-sparing procedures. 20 patients with non-resect
able, locally advanced primary or recurring rectal carcinoma T3/4 ente
red a phase I/II study of pre-operative radiochemothermotherapy with f
olinic acid and 5-fluorouracil, radiation (45 Gy HD), as well as regio
nal hyperthermia once a week followed by chemotherapy after surgery. T
he regimen proved to be sufficiently tolerable. Acute grade III or IV
toxicities did not occur after hyperthermia. Tumour resections were pe
rformed on 14 of the 20 patients, with 13 being complete. In 9 of the
carcinomas, downstaging compared with the pretherapeutic stage was ach
ieved. In 3 of 6 patients with persistent non-resectable tumours, loca
l control has now been maintained for more than 12 months. One patient
progressed locally during neoadjuvant combination therapy. These resu
lts prompted the initiation of a prospective randomised study to evalu
ate the relative importance of regional hyperthermia in this setting.